DexCom Inc. (DXCM)

208.37
NASDAQ : Health Technology
Prev Close 202.81
Day Low/High 202.02 / 208.38
52 Wk Low/High 105.05 / 208.20
Avg Volume 938.80K
Exchange NASDAQ
Shares Outstanding 91.19M
Market Cap 18.49B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Dexcom Announces Upcoming Conference Presentation

Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company...

China Gets Serious, Trading Roku: Market Recon

China Gets Serious, Trading Roku: Market Recon

As for pressure on the Chinese side, I think a September 17.8% decline in exports to the U.S. compounded on top of a 22% decline in August speaks for itself.

Dexcom Reports Third Quarter 2019 Financial Results

Dexcom Reports Third Quarter 2019 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2019.

U.S. Treasury Yield Curve, Oil Market Valuations, Trading Adobe: Market Recon

U.S. Treasury Yield Curve, Oil Market Valuations, Trading Adobe: Market Recon

OPEC forecasts declining demand for OPEC oil, not a decline in global demand. That distinction is key.

All Eyes on Earnings: Cramer's 'Mad Money' Recap (Friday 11/1/19)

All Eyes on Earnings: Cramer's 'Mad Money' Recap (Friday 11/1/19)

Jim Cramer says strong earnings reports next week could sustain the rally. He's got your game plan.

DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump

DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump

Tandem will include Abbott's Libre sensor in its insulin pump.

Dexcom Schedules Third Quarter 2019 Earnings Release And Conference Call For November 6, 2019 At 4:30 P.m. Eastern Time

Dexcom Schedules Third Quarter 2019 Earnings Release And Conference Call For November 6, 2019 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2019 financial results after market close on Wednesday, November 6, 2019.

Dexcom Announces FDA Clearance Of New Dexcom G6 Pro CGM

Dexcom Announces FDA Clearance Of New Dexcom G6 Pro CGM

Dexcom, Inc. (NASDAQ:DXCM) announced today the U.

Dexcom Promotes Quentin Blackford To Chief Operating Officer

Dexcom Promotes Quentin Blackford To Chief Operating Officer

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Quentin Blackford to the role of Chief Operating Officer (COO) in addition to his duties as Chief Financial Officer.

Dexcom Appoints Bridgette Heller To Board Of Directors

Dexcom Appoints Bridgette Heller To Board Of Directors

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Bridgette Heller to its Board of Directors, effective immediately.

Dexcom G6® CGM System Now Available In Canada

Dexcom G6® CGM System Now Available In Canada

Revolutionary new Continuous Glucose Monitoring System eliminates fingersticks* for people with diabetes VANCOUVER, Sept.

Dexcom Announces Upcoming Conference Presentations

Dexcom Announces Upcoming Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conferences: Quentin Blackford, Executive Vice President and Chief Financial Officer, and Steven Pacelli, Executive Vice...

Dexcom Reports Second Quarter 2019 Financial Results

Dexcom Reports Second Quarter 2019 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2019.

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Jim Cramer says higher sales, higher prices, and demand from emerging markets seem to be fueling a return to the days of great senior growth stocks.

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Jim Cramer weighs in on Pfizer, eBay, Cloudera, Cadence Systems, CRISPR Therapeutics, Moderna, Tandem Diabetes Care, and more.

Dexcom Schedules Second Quarter 2019 Earnings Release And Conference Call For July 31, 2019 At 4:30 P.m. Eastern Time

Dexcom Schedules Second Quarter 2019 Earnings Release And Conference Call For July 31, 2019 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2019 financial results after market close on Wednesday, July 31, 2019.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMEH, ATLC, DXCM, FBHS, HRI, OPOF Downgrades: PRSC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Dexcom Looks Like It Can Finally Break Out on the Topside

Dexcom Looks Like It Can Finally Break Out on the Topside

Let's check the charts and indicators on the glucose-monitoring company.

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

Jim Cramer looks at retail, specifically the companies that are doing well for working-class Americans, and those that cater to high-end customers -- a 'barbell economy,' he says.

Dexcom And Companion Medical Announce Collaboration To Integrate Dexcom CGM Data And InPen™ Insulin Data

Dexcom And Companion Medical Announce Collaboration To Integrate Dexcom CGM Data And InPen™ Insulin Data

DexCom, Inc. (NASDAQ:DXCM) and Companion Medical, Inc.

Dexcom Announces Upcoming Conference Presentation

Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company...

One-Two Punch: Cramer's 'Mad Money' Recap (Tuesday 5/7/19)

One-Two Punch: Cramer's 'Mad Money' Recap (Tuesday 5/7/19)

Jim Cramer's worried the market could reel from the tariff increases and a disappointing Uber IPO. He says investors need to brace for the possibilities.

Starbucks, DexCom, HealthEquity: 'Mad Money' Lightning Round

Starbucks, DexCom, HealthEquity: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Starbucks, DexCom, HealthEquity, Turning Point Brands, Tilray, CVS Health, Timken and more.

Dexcom Reports First Quarter 2019 Financial Results

Dexcom Reports First Quarter 2019 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2019.

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at DexCom, HCA Healthcare, Tractor Supply, Sarepta Therapeutics, The Blackstone Group, HNI Corp. and more.

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Jim Cramer says it's the start CNBC's annual Stock Draft Contest, but he cautions Mad Money viewers that although investing can be fun, it requires discipline and doing your homework.

A Telecom Supplier, an Appliance Maker and Other Stocks That Look Good Short

FNV, NOK, HBB, DXCM and MG all recently were downgraded by TheStreet's Quant Ratings.

TheStreet Quant Rating: C (Hold)